Evidence map›Paper›PMID 25681501›Full record

ArticleJournal of cell science2015

Sulf1 has ligand-dependent effects on canonical and non-canonical Wnt signalling.

Simon W Fellgett, Richard J Maguire, Mary Elizabeth Pownall

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Simon W FellgettBiology Department, University of York, York YO10 5YW, UK.
Richard J MaguireBiology Department, University of York, York YO10 5YW, UK.
Mary Elizabeth PownallBiology Department, University of York, York YO10 5YW, UK betsy.pownall@york.ac.uk.
University of York · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H010297/1Medical Research Council
6 · The paper itself

Abstract

Wnt signalling plays essential roles during embryonic development and is known to be mis-regulated in human disease. There are many molecular mechanisms that ensure tight regulation of Wnt activity. One such regulator is the heparan-sulfate-specific 6-O-endosulfatase Sulf1. Sulf1 acts extracellularly to modify the structure of heparan sulfate chains to affect the bio-availability of Wnt ligands. Sulf1 could, therefore, influence the formation of Wnt signalling complexes to modulate the activation of both canonical and non-canonical pathways. In this study, we use well-established assays in Xenopus to investigate the ability of Sulf1 to modify canonical and non-canonical Wnt signalling. In addition, we model the ability of Sulf1 to influence morphogen gradients using fluorescently tagged Wnt ligands in ectodermal explants. We show that Sulf1 overexpression has ligand-specific effects on Wnt signalling: it affects membrane accumulation and extracellular levels of tagged Wnt8a and Wnt11b ligands differently, and inhibits the activity of canonical Wnt8a but enhances the activity of non-canonical Wnt11b.

Indexed as

Signal TransductionAnimalsLigandsSulfatasesWnt3A ProteinWnt ProteinsXenopus laevisXenopus ProteinsZebrafish ProteinsLigandsSulf1 protein, zebrafishSulfataseswnt11b protein, XenopusWnt3A ProteinWnt3a protein, zebrafishwnt8a protein, XenopusWnt ProteinsXenopus ProteinsZebrafish Proteins6-O-endosulfataseCell signallingDevelopmentHeparan sulfateHSPGMorphogenPronephrosWnt

Identifiers

PMID25681501
PMCPMC4379729
OpenAlexW2130543999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.